| IFRD2 |
Q12894
|
interferon related developmental regulator 2
|
|
1.1E-09 |
1.000 |
0.038 |
| CIAO2A |
Q9H5X1
|
cytosolic iron-sulfur assembly component 2A
|
|
2.0E-05 |
0.931 |
0.077 |
| CEACAM20 |
Q6UY09
|
CEA cell adhesion molecule 20
|
|
|
0.931 |
0.115 |
| CLQTL1 |
|
cholesterol-lowering factor
|
|
|
0.890 |
0.115 |
| C19orf33 |
Q9GZP8
|
chromosome 19 open reading frame 33
|
|
0.70 |
0.861 |
0.115 |
| SPIC |
Q8N5J4
|
Spi-C transcription factor
|
Transcription factor
|
0.31 |
0.861 |
0.154 |
| IBD3 |
|
inflammatory bowel disease 3
|
|
|
0.861 |
0.038 |
| CWC22 |
Q9HCG8
|
CWC22 spliceosome associated protein homolog
|
Enzyme
|
9.0E-04 |
0.861 |
0.115 |
| GAB3 |
Q8WWW8
|
GRB2 associated binding protein 3
|
Receptor
|
0.95 |
0.839 |
0.231 |
| ITIH2 |
P19823
|
inter-alpha-trypsin inhibitor heavy chain 2
|
Enzyme modulator
|
3.8E-23 |
0.839 |
0.308 |
| SLC9A2 |
Q9UBY0
|
solute carrier family 9 member A2
|
Transporter
|
2.4E-03 |
0.839 |
0.308 |
| EIM |
|
Infantile myoclonic epilepsy
|
|
|
0.839 |
0.269 |
| LYPD8 |
Q6UX82
|
LY6/PLAUR domain containing 8
|
|
|
0.839 |
0.115 |
| WDR13 |
Q9H1Z4
|
WD repeat domain 13
|
|
0.94 |
0.839 |
0.154 |
| ERGIC2 |
Q96RQ1
|
ERGIC and golgi 2
|
|
1.3E-02 |
0.821 |
0.308 |
| FNDC4 |
Q9H6D8
|
fibronectin type III domain containing 4
|
|
0.88 |
0.821 |
0.192 |
| FAM3D |
Q96BQ1
|
FAM3 metabolism regulating signaling molecule D
|
|
2.4E-04 |
0.821 |
0.269 |
| WDR7 |
Q9Y4E6
|
WD repeat domain 7
|
|
1.00 |
0.821 |
0.077 |
| SGPP2 |
Q8IWX5
|
sphingosine-1-phosphate phosphatase 2
|
Enzyme
|
2.8E-03 |
0.805 |
0.154 |
| IBD2 |
|
inflammatory bowel disease 2
|
|
|
0.805 |
0.154 |
| MSMP |
Q1L6U9
|
microseminoprotein, prostate associated
|
|
4.8E-02 |
0.805 |
0.154 |
| LY86 |
O95711
|
lymphocyte antigen 86
|
|
2.3E-05 |
0.805 |
0.231 |
| TAOK1 |
Q7L7X3
|
TAO kinase 1
|
Kinase
|
1.00 |
0.792 |
0.269 |
| SGPP1 |
Q9BX95
|
sphingosine-1-phosphate phosphatase 1
|
Enzyme
|
1.4E-04 |
0.792 |
0.192 |
| CHST4 |
Q8NCG5
|
carbohydrate sulfotransferase 4
|
|
2.0E-09 |
0.792 |
0.269 |